Hot Features
Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
| Datum | Name des Inhabers | Gehandelte Aktien | Wertspanne ($) | Transaktionstyp | Preisspanne ($) | Aktien am Meldungsende | % Veränderung |
|---|---|---|---|---|---|---|---|
| 2026-06-03 | Mr. Michael Daniel VerdeschiMD & CFO | -6,52k | 569,89k | Sale to Issuer | 87,42 | 47,44k | -12,08% |
| 2026-05-28 | Mr. Richard Andrew WursterCEO, President & Director | 21,96k | 1,85M | Kauf | 84,23 | 223,00k | 10,92% |
| 2026-05-22 | Mr. Charles R. SchwabInsider | -210,00k | 0,00 | Other Disposition | - | 14,46M | -1,43% |
| 2026-05-21 | Ms. Joan T. DeaIndependent Director | -835,00 | 0,00 | Other Disposition | - | 22,77k | -3,54% |
| 2026-05-15 | Mr. Charles R. SchwabInsider | -5,30k | 0,00 | Other Disposition | - | 14,67M | -0,04% |
| 2026-05-13 | Mr. Arun SarinIndependent Director | 5,37k | 155,40k | Derivative Exercise and Retained Stock | 28,96 | 30,58k | 21,28% |
| 2026-05-13 | Mr. Arun SarinIndependent Director | -2,50k | 155,51k | Derivative Exercise and Sale | 28,96 - 91,16 | 30,58k | - |
| 2026-05-05 | Ms. Carolyn Schwab-PomerantzDirector | -9,91k | 600,96k | Derivative Exercise and Sale | 31,65 - 92,29 | 1,85M | - |
| 2026-04-29 | Mr. Charles R. SchwabInsider | -168,74k | 15,41M | Verkauf | 90,49 - 91,86 | 15,79M | -1,06% |
| 2026-04-28 | Mr. Frank C. HerringerIndependent Director | 5,35k | 154,82k | Derivative Exercise and Retained Stock | 28,96 | 234,73k | 2,33% |
| 2026-04-28 | Mr. Frank C. HerringerIndependent Director | -2,52k | 155,33k | Derivative Exercise and Sale | 28,96 - 90,60 | 234,73k | - |
| 2026-04-23 | Mr. Charles R. SchwabInsider | -72,90k | 6,58M | Verkauf | 90,00 - 90,50 | 15,96M | -0,45% |
| 2026-04-14 | Mr. Paul V. WoolwayMD & Chief Banking Officer | -15,88k | 745,77k | Derivative Exercise and Sale | 52,05 - 100,00 | 46,73k | - |
| 2026-04-14 | Mr. Jonathan M. CraigMD, Head of Investor Service & Head of Retail Investing | -21,75k | 1,14M | Derivative Exercise and Sale | 46,81 - 99,00 | - | - |
| 2026-04-14 | Mr. Nigel J. MurtaghMD & Chief Risk Officer | -41,30k | 1,94M | Derivative Exercise and Sale | 52,05 - 99,00 | 60,46k | - |
| 2026-03-24 | Mr. Stephen A. EllisIndependent Director | 9,77k | 281,69k | Derivative Exercise and Retained Stock | 28,38 - 28,96 | 99,92k | 10,83% |
| 2026-03-03 | Mr. Nigel J. MurtaghMD & Chief Risk Officer | -7,20k | 681,45k | Automatic Disposition | 94,43 - 94,90 | 60,46k | -10,65% |
| 2026-03-03 | Mr. Jonathan M. CraigMD, Head of Investor Service & Head of Retail Investing | -14,48k | 1,37M | Automatic Disposition | 94,42 - 94,89 | 0,00 | -100,00% |
| 2026-03-03 | Mr. Dennis Willard HowardMD and Chief Technology, Operations & Data Officer | -10,11k | 956,23k | Automatic Disposition | 94,43 - 94,88 | 10,47k | -49,12% |
| 2026-03-02 | Mr. Paul V. WoolwayMD & Chief Banking Officer | -15,88k | 684,05k | Derivative Exercise and Sale | 52,05 - 96,00 | 46,73k | - |
| 2026-03-03 | Mr. Paul V. WoolwayMD & Chief Banking Officer | -6,13k | 579,57k | Automatic Disposition | 94,41 - 94,89 | 46,73k | -11,59% |
| 2026-03-01 | Mr. Paul V. WoolwayMD & Chief Banking Officer | -2,03k | 183,32k | Sale to Issuer | 90,31 | 46,73k | -4,16% |
| 2026-03-01 | Mr. Jonathan M. CraigMD, Head of Investor Service & Head of Retail Investing | -11,15k | 1,06M | Sale to Issuer | 95,31 | 14,48k | -43,51% |
| 2026-03-01 | Mr. Nigel J. MurtaghMD & Chief Risk Officer | -9,11k | 868,13k | Sale to Issuer | 95,31 | 67,55k | -11,88% |
| 2026-03-01 | Mr. Dennis Willard HowardMD and Chief Technology, Operations & Data Officer | -6,20k | 591,27k | Sale to Issuer | 95,31 | 10,11k | -38,03% |
| 2026-03-01 | Mr. Charles R. SchwabInsider | -15,28k | 1,46M | Sale to Issuer | 95,31 | 16,03M | -0,10% |
| 2026-03-01 | Mr. Walter William BettingerCo-Chairman | -60,74k | 5,79M | Sale to Issuer | 95,31 | 623,94k | -8,87% |
| 2026-03-01 | Mr. Richard Andrew WursterCEO, President & Director | -22,88k | 2,18M | Sale to Issuer | 95,31 | 200,78k | -10,23% |
| 2026-03-01 | Mr. Peter J. MorganMD, General Counsel & Corporate Secretary | -4,31k | 410,86k | Sale to Issuer | 95,31 | 7,65k | -36,04% |
| 2026-02-27 | Mr. Jonathan Scott BeattyMD & Head of Schwab Advisor Services | -2,03k | 193,45k | Verkauf | 95,30 | 25,50k | -7,37% |
| 2026-02-26 | Mr. Stephen A. EllisIndependent Director | -10,73k | 1,04M | Verkauf | 96,57 | 83,50k | -11,38% |
| 2026-02-25 | Mr. Dennis Willard HowardMD and Chief Technology, Operations & Data Officer | -27,90k | 862,76k | Derivative Exercise and Sale | 64,10 - 95,02 | 0,00 | - |
| 2026-02-09 | Mr. Charles R. SchwabInsider | -60,00k | 0,00 | Other Disposition | - | 16,01M | -0,37% |
| 2026-02-06 | Mr. Walter William BettingerCo-Chairman | -67,51k | 4,14M | Derivative Exercise and Sale | 42,99 - 104,25 | 542,93k | - |
| 2026-02-06 | Mr. Christopher Vincent DoddsIndependent Director | -11,83k | 479,17k | Derivative Exercise and Sale | 51,97 - 104,55 | 449,41k | - |
| 2026-02-03 | Mr. Charles R. SchwabInsider | -164,60k | 17,08M | Verkauf | 103,74 - 103,81 | 16,07M | -1,01% |
| 2026-02-03 | Mr. Walter William BettingerCo-Chairman | -257,41k | 15,71M | Derivative Exercise and Sale | 42,99 - 104,25 | 542,93k | - |
| 2026-02-02 | Mr. Peter J. MorganMD, General Counsel & Corporate Secretary | -7,60k | 287,96k | Derivative Exercise and Sale | 66,47 - 104,38 | 700,00 | - |
| 2026-01-29 | Mr. Charles R. SchwabInsider | -145,65k | 15,03M | Verkauf | 103,16 | 16,24M | -0,89% |
| 2026-01-28 | Mr. Charles R. SchwabInsider | -71,44k | 7,37M | Verkauf | 103,20 - 103,22 | 16,38M | -0,43% |
| 2026-01-22 | Ms. Carolyn Schwab-PomerantzDirector | -42,87k | 4,51M | Verkauf | 105,02 - 105,25 | 1,85M | -2,27% |
| 2026-01-22 | Mr. Jonathan Scott BeattyMD & Head of Schwab Advisor Services | -2,00k | 117,22k | Derivative Exercise and Sale | 46,39 - 105,00 | 27,53k | - |
| 2025-12-23 | Mr. Jonathan Scott BeattyMD & Head of Schwab Advisor Services | -2,00k | 111,24k | Derivative Exercise and Sale | 46,39 - 102,01 | 27,53k | - |
| 2025-12-16 | Mr. Stephen A. EllisIndependent Director | 1,92k | 61,47k | Derivative Exercise and Retained Stock | 31,98 | 100,55k | 1,95% |
| 2025-11-19 | Mr. Charles Anthony RuffelIndependent Director | -8,37k | 0,00 | Other Disposition | - | 18,87k | -30,74% |
| 2025-11-12 | Mr. Nigel J. MurtaghMD & Chief Risk Officer | -1,03k | 0,00 | Other Disposition | - | 60,35k | -1,68% |
| 2025-11-12 | Mr. Jonathan Scott BeattyMD & Head of Schwab Advisor Services | -3,07k | 158,55k | Derivative Exercise and Sale | 46,39 - 98,00 | 27,53k | - |
| 2025-11-13 | Ms. Paula A. SneedIndependent Director | -8,68k | 0,00 | Other Disposition | - | 100,98k | -7,92% |
| 2025-11-12 | Mr. Charles R. SchwabInsider | -52,50k | 0,00 | Other Disposition | - | - | - |
| 2025-11-10 | Ms. Carolyn Schwab-PomerantzDirector | -298,00 | 0,00 | Other Disposition | - | 1,89M | -0,02% |
| 2025-11-10 | Mr. Walter William BettingerCo-Chairman | -61,39k | 0,00 | Other Disposition | - | 542,65k | -10,16% |
| 2025-11-10 | Mr. Paul V. WoolwayMD & Chief Banking Officer | -1,09k | 0,00 | Other Disposition | - | 46,70k | -2,28% |
| 2025-11-07 | Mr. Jonathan M. CraigMD, Head of Investor Service & Head of Retail Investing | -35,19k | 1,88M | Derivative Exercise and Sale | 41,98 - 95,35 | 0,00 | - |
| 2025-10-28 | Mr. Charles R. SchwabInsider | -109,15k | 10,28M | Verkauf | 94,00 - 94,52 | - | - |
| 2025-10-29 | Mr. Paul V. WoolwayMD & Chief Banking Officer | -3,82k | 0,00 | Other Disposition | - | 46,99k | -7,52% |
| 2025-10-23 | Mr. Charles R. SchwabInsider | -50,35k | 0,00 | Other Disposition | - | - | - |
| 2025-10-02 | Ms. Carolyn Schwab-PomerantzDirector | -24,00k | 2,22M | Automatic Disposition | 92,55 | 1,89M | -1,26% |
| 2025-10-01 | Mr. Paul V. WoolwayMD & Chief Banking Officer | -3,21k | 299,11k | Automatic Disposition | 93,04 - 93,74 | 50,81k | -5,93% |
| 2025-09-23 | Mr. Stephen A. EllisIndependent Director | 2,11k | 60,10k | Derivative Exercise and Retained Stock | 28,55 | 98,35k | 2,19% |
| 2025-09-04 | Ms. Carolyn Schwab-PomerantzDirector | -24,00k | 2,32M | Automatic Disposition | 96,64 | 1,91M | -1,24% |
| 2025-09-02 | Mr. Paul V. WoolwayMD & Chief Banking Officer | -3,21k | 305,13k | Automatic Disposition | 95,20 | 54,02k | -5,60% |
| 2025-08-28 | Mr. Jonathan Scott BeattyMD & Head of Schwab Advisor Services | -6,14k | 309,79k | Derivative Exercise and Sale | 46,39 - 96,81 | 27,53k | - |
| 2025-08-27 | Mr. Jonathan Scott BeattyMD & Head of Schwab Advisor Services | -3,30k | 320,31k | Verkauf | 97,18 | 27,53k | -10,69% |
| 2025-08-27 | Mr. Peter J. MorganMD, General Counsel & Corporate Secretary | -50,02k | 1,68M | Derivative Exercise and Sale | 46,39 - 97,00 | 601,00 | - |
| 2025-08-26 | Mr. Charles R. SchwabInsider | -273,00k | 26,44M | Verkauf | 96,67 - 97,04 | - | - |
| 2025-08-25 | Ms. Carolyn Schwab-PomerantzDirector | -13,54k | 1,30M | Verkauf | 96,06 | 1,94M | -0,69% |
| 2025-08-07 | Mr. Charles R. SchwabInsider | -155,87k | 15,07M | Verkauf | 96,02 - 96,84 | - | - |
| 2025-08-07 | Ms. Carolyn Schwab-PomerantzDirector | -24,00k | 2,32M | Automatic Disposition | 96,68 - 97,22 | 1,95M | -1,22% |
| 2025-08-01 | Mr. Paul V. WoolwayMD & Chief Banking Officer | -3,29k | 316,04k | Verkauf | 96,06 | 57,22k | -5,44% |
| 2025-07-29 | Mr. Walter William BettingerCo-Chairman | -173,88k | 17,19M | Verkauf | 98,84 | 603,96k | -22,35% |
| 2025-07-29 | Mr. Richard Andrew WursterCEO, President & Director | -20,50k | 2,03M | Verkauf | 99,16 | 161,52k | -11,26% |
| 2025-07-29 | Mr. Nigel J. MurtaghMD & Chief Risk Officer | -24,10k | 1,35M | Derivative Exercise and Sale | 41,98 - 97,91 | 61,37k | - |
| 2025-07-29 | Ms. Joan T. DeaIndependent Director | -513,00 | 0,00 | Other Disposition | - | 23,61k | -2,13% |
| 2025-07-03 | Ms. Carolyn Schwab-PomerantzDirector | -24,00k | 2,20M | Automatic Disposition | 91,59 | 1,97M | -1,20% |
| 2025-07-01 | Mr. Jonathan Scott BeattyMD & Head of Schwab Advisor Services | -1,04k | 93,91k | Sale to Issuer | 90,74 | 24,38k | -4,07% |
| 2025-07-01 | Mr. Paul V. WoolwayMD & Chief Banking Officer | -3,29k | 299,22k | Automatic Disposition | 90,95 | 64,11k | -4,88% |
| 2025-06-24 | Mr. Stephen A. EllisIndependent Director | 1,85k | 61,37k | Derivative Exercise and Retained Stock | 33,12 | 95,98k | 1,97% |
Die zuletzt besuchten Aktien werden in diesem Feld angezeigt, so dass Sie leicht zu den Aktien zurückkehren können, die Sie zuvor angesehen haben.
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Mit E-Mail registrieren
Haben Sie schon ein Konto? Anmelden
Haben Sie kein Konto? Registrieren
Durch die Registrierung bestätige ich, dass ich die Allgemeinen Geschäftsbedingungen von ADVFN gelesen und verstanden habe und ihnen zustimme und dass ich ein Privatinvestor bin.
Premium
